Birdwatch Note
2024-05-21 13:05:59 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Le Pr Raoult présente des données de manière trompeuses Si des protéines alternatives ont pu être produites aucune réaction d’autoimmunité particulière n’a été retrouvée après de milliards de doses https://sfpt-fr.org/avis-de-la-sfpt/pharmacoflash/1941-fl003-synth%C3%A8se-de-prot%C3%A9ines-alternatives-induite-par-les-vaccins-arnm Seuls de fragment de dégradation d'Adn sont retrouvés sans preuve d'intégration
Written by 3808C1C8861A3AC9CC4708577DB64D6B06ECFD5E363CB00308558C53EE83C906
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1792867336954757164
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1792904674196025559
- noteId - 1792904674196025559
- participantId -
- noteAuthorParticipantId - 3808C1C8861A3AC9CC4708577DB64D6B06ECFD5E363CB00308558C53EE83C906 Participant Details
- createdAtMillis - 1716296759542
- tweetId - 1792867336954757164
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Le Pr Raoult présente des données de manière trompeuses Si des protéines alternatives ont pu être produites aucune réaction d’autoimmunité particulière n’a été retrouvée après de milliards de doses https://sfpt-fr.org/avis-de-la-sfpt/pharmacoflash/1941-fl003-synth%C3%A8se-de-prot%C3%A9ines-alternatives-induite-par-les-vaccins-arnm Seuls de fragment de dégradation d'Adn sont retrouvés sans preuve d'intégration
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-05-21 13:05:59 UTC (1716296759542) |
2024-05-21 15:31:50 UTC (1716305510939) |
CURRENTLY_RATED_HELPFUL | 2024-05-22 01:14:11 UTC (1716340451856) |
NEEDS_MORE_RATINGS | 2024-05-21 15:31:50 UTC (1716305510939) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-05-21 19:18:57 -0500 | Rating Details | |
| 2024-05-21 17:53:55 -0500 | Rating Details | |
| 2024-05-21 16:41:22 -0500 | Rating Details | |
| 2024-05-21 16:38:02 -0500 | Rating Details | |
| 2024-05-21 16:05:45 -0500 | Rating Details | |
| 2024-05-21 16:01:02 -0500 | Rating Details | |
| 2024-05-21 15:46:34 -0500 | Rating Details | |
| 2024-05-21 14:52:29 -0500 | Rating Details | |
| 2024-05-21 14:22:10 -0500 | Rating Details | |
| 2024-05-21 13:37:25 -0500 | Rating Details | |
| 2024-05-21 13:35:42 -0500 | Rating Details | |
| 2024-05-21 13:14:15 -0500 | Rating Details | |
| 2024-05-21 13:13:54 -0500 | Rating Details | |
| 2024-05-21 12:46:53 -0500 | Rating Details | |
| 2024-05-21 12:38:56 -0500 | Rating Details | |
| 2024-05-21 12:23:46 -0500 | Rating Details | |
| 2024-05-21 12:17:38 -0500 | Rating Details | |
| 2024-05-21 11:45:31 -0500 | Rating Details | |
| 2024-05-21 10:52:23 -0500 | Rating Details | |
| 2024-05-21 10:43:08 -0500 | Rating Details | |
| 2024-05-21 10:34:16 -0500 | Rating Details | |
| 2024-05-21 10:28:33 -0500 | Rating Details | |
| 2024-05-21 09:36:20 -0500 | Rating Details | |
| 2024-05-21 09:35:18 -0500 | Rating Details | |
| 2024-05-21 09:27:53 -0500 | Rating Details | |
| 2024-05-21 09:07:13 -0500 | Rating Details | |
| 2024-05-21 08:58:01 -0500 | Rating Details | |
| 2024-05-21 08:55:24 -0500 | Rating Details | |
| 2024-05-21 08:37:35 -0500 | Rating Details | |
| 2024-05-21 08:25:39 -0500 | Rating Details | |
| 2024-05-22 16:08:53 -0500 | Rating Details | |
| 2024-05-22 12:05:18 -0500 | Rating Details | |
| 2024-05-22 06:00:08 -0500 | Rating Details | |
| 2024-05-22 03:58:37 -0500 | Rating Details | |
| 2024-05-22 02:11:02 -0500 | Rating Details | |
| 2024-05-21 23:19:44 -0500 | Rating Details | |
| 2024-05-21 19:50:25 -0500 | Rating Details | |
| 2024-05-23 15:26:26 -0500 | Rating Details | |
| 2024-05-23 02:38:09 -0500 | Rating Details | |
| 2024-05-22 23:11:28 -0500 | Rating Details | |
| 2024-05-22 23:06:09 -0500 | Rating Details | |
| 2024-05-22 17:36:43 -0500 | Rating Details | |
| 2024-05-22 01:34:43 -0500 | Rating Details | |
| 2024-05-21 23:49:06 -0500 | Rating Details | |
| 2024-05-21 15:53:28 -0500 | Rating Details | |
| 2024-05-21 15:18:07 -0500 | Rating Details | |
| 2024-05-21 14:58:19 -0500 | Rating Details | |
| 2024-05-21 14:13:55 -0500 | Rating Details | |
| 2024-05-21 14:06:37 -0500 | Rating Details | |
| 2024-05-21 13:57:28 -0500 | Rating Details | |
| 2024-05-21 13:28:54 -0500 | Rating Details | |
| 2024-05-21 13:27:51 -0500 | Rating Details | |
| 2024-05-21 13:20:33 -0500 | Rating Details | |
| 2024-05-21 13:12:23 -0500 | Rating Details | |
| 2024-05-21 13:08:27 -0500 | Rating Details | |
| 2024-05-21 12:48:33 -0500 | Rating Details | |
| 2024-05-21 12:43:53 -0500 | Rating Details | |
| 2024-05-21 12:36:43 -0500 | Rating Details | |
| 2024-05-21 12:17:06 -0500 | Rating Details | |
| 2024-05-21 11:55:21 -0500 | Rating Details | |
| 2024-05-21 11:47:30 -0500 | Rating Details | |
| 2024-05-21 11:33:48 -0500 | Rating Details | |
| 2024-05-21 10:53:33 -0500 | Rating Details | |
| 2024-05-21 10:08:53 -0500 | Rating Details | |
| 2024-05-21 10:01:00 -0500 | Rating Details | |
| 2024-05-21 09:51:04 -0500 | Rating Details | |
| 2024-05-21 09:45:30 -0500 | Rating Details | |
| 2024-05-21 09:23:50 -0500 | Rating Details | |
| 2024-05-21 09:19:31 -0500 | Rating Details | |
| 2024-05-21 08:48:11 -0500 | Rating Details | |
| 2024-05-21 08:25:31 -0500 | Rating Details | |
| 2024-05-21 08:13:08 -0500 | Rating Details | |
| 2024-05-23 01:27:27 -0500 | Rating Details | |
| 2024-05-21 14:50:33 -0500 | Rating Details | |
| 2024-05-21 11:49:56 -0500 | Rating Details | |
| 2024-05-23 07:43:51 -0500 | Rating Details | |
| 2024-05-23 05:38:19 -0500 | Rating Details | |
| 2024-05-23 01:35:15 -0500 | Rating Details | |
| 2024-05-23 00:07:23 -0500 | Rating Details | |
| 2024-05-22 17:40:03 -0500 | Rating Details | |
| 2024-05-22 16:09:11 -0500 | Rating Details | |
| 2024-05-22 15:16:50 -0500 | Rating Details | |
| 2024-05-22 08:36:15 -0500 | Rating Details | |
| 2024-05-21 19:09:11 -0500 | Rating Details | |
| 2024-05-21 18:01:31 -0500 | Rating Details | |
| 2024-05-21 17:31:17 -0500 | Rating Details | |
| 2024-05-21 16:30:03 -0500 | Rating Details | |
| 2024-05-21 16:06:11 -0500 | Rating Details | |
| 2024-05-21 15:49:59 -0500 | Rating Details | |
| 2024-05-21 14:05:49 -0500 | Rating Details | |
| 2024-05-21 13:59:28 -0500 | Rating Details | |
| 2024-05-21 13:56:59 -0500 | Rating Details | |
| 2024-05-21 13:47:37 -0500 | Rating Details | |
| 2024-05-21 12:33:11 -0500 | Rating Details | |
| 2024-05-21 12:14:31 -0500 | Rating Details | |
| 2024-05-21 12:07:38 -0500 | Rating Details | |
| 2024-05-21 11:49:07 -0500 | Rating Details | |
| 2024-05-21 11:40:33 -0500 | Rating Details | |
| 2024-05-21 11:22:35 -0500 | Rating Details | |
| 2024-05-21 10:53:09 -0500 | Rating Details | |
| 2024-05-21 10:32:39 -0500 | Rating Details | |
| 2024-05-21 10:22:56 -0500 | Rating Details | |
| 2024-05-21 10:15:47 -0500 | Rating Details | |
| 2024-05-21 10:11:00 -0500 | Rating Details | |
| 2024-05-21 10:02:04 -0500 | Rating Details | |
| 2024-05-21 09:31:34 -0500 | Rating Details | |
| 2024-05-21 09:24:16 -0500 | Rating Details | |
| 2024-05-21 09:01:32 -0500 | Rating Details | |
| 2024-05-21 08:55:51 -0500 | Rating Details | |
| 2024-05-21 08:42:03 -0500 | Rating Details | |
| 2024-05-23 04:46:18 -0500 | Rating Details | |
| 2024-05-21 12:48:35 -0500 | Rating Details |